Arcutis Biotherapeutics, Inc.
Arcutis Biotherapeutics, Inc., a biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases. Its lead product candidate is ARQ-151, a topical roflumilast cream that has completed Phase III clinical trials …
Biotechnology
US, Westlake Village [HQ]
Similar Stocks · Benchmarked Analysis · Peer Group
Peers Performance
Similar Stocks · Adjusted CloseA quick analysis that compared Arcutis Biotherapeutics, Inc. (ARQT) to it's peer group.
Peer Group
APLS MRTX AMLX XFOR DAWN SPRO MIRM NLTX BOLT ICVX DSGN GLUE ERAS TERN INZY ABOS CHRS THRX
Compare Together
Loading...